198 related articles for article (PubMed ID: 28860737)
1. Risk of community-acquired pneumonia in chronic obstructive pulmonary disease stratified by smoking status: a population-based cohort study in the United Kingdom.
Braeken DC; Rohde GG; Franssen FM; Driessen JH; van Staa TP; Souverein PC; Wouters EF; de Vries F
Int J Chron Obstruct Pulmon Dis; 2017; 12():2425-2432. PubMed ID: 28860737
[TBL] [Abstract][Full Text] [Related]
2. Comorbid pulmonary disease and risk of community-acquired pneumonia in COPD patients.
Lin SH; Ji BC; Shih YM; Chen CH; Chan PC; Chang YJ; Lin YC; Lin CH
Int J Tuberc Lung Dis; 2013 Dec; 17(12):1638-44. PubMed ID: 24200282
[TBL] [Abstract][Full Text] [Related]
3. Seasonality, risk factors and burden of community-acquired pneumonia in COPD patients: a population database study using linked health care records.
Williams NP; Coombs NA; Johnson MJ; Josephs LK; Rigge LA; Staples KJ; Thomas M; Wilkinson TM
Int J Chron Obstruct Pulmon Dis; 2017; 12():313-322. PubMed ID: 28176888
[TBL] [Abstract][Full Text] [Related]
4. Increased risk of community-acquired pneumonia in COPD patients with comorbid cardiovascular disease.
Lin SH; Perng DW; Chen CP; Chai WH; Yeh CS; Kor CT; Cheng SL; Chen JJ; Lin CH
Int J Chron Obstruct Pulmon Dis; 2016; 11():3051-3058. PubMed ID: 27980402
[TBL] [Abstract][Full Text] [Related]
5. Community-acquired pneumonia and survival of critically ill acute exacerbation of COPD patients in respiratory intensive care units.
Lu Z; Cheng Y; Tu X; Chen L; Chen H; Yang J; Wang J; Zhang L
Int J Chron Obstruct Pulmon Dis; 2016; 11():1867-72. PubMed ID: 27563239
[TBL] [Abstract][Full Text] [Related]
6. The natural history of community-acquired pneumonia in COPD patients: a population database analysis.
Müllerova H; Chigbo C; Hagan GW; Woodhead MA; Miravitlles M; Davis KJ; Wedzicha JA
Respir Med; 2012 Aug; 106(8):1124-33. PubMed ID: 22621820
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcomes in patients with COPD hospitalized with SARS-CoV-2 versus non- SARS-CoV-2 community-acquired pneumonia.
Sheikh D; Tripathi N; Chandler TR; Furmanek S; Bordon J; Ramirez JA; Cavallazzi R
Respir Med; 2022 Jan; 191():106714. PubMed ID: 34915396
[TBL] [Abstract][Full Text] [Related]
8. Hospitalization due to community-acquired pneumonia in patients with chronic obstructive pulmonary disease: incidence, epidemiology and outcomes.
Bordon J; Slomka M; Gupta R; Furmanek S; Cavallazzi R; Sethi S; Niederman M; Ramirez JA;
Clin Microbiol Infect; 2020 Feb; 26(2):220-226. PubMed ID: 31254714
[TBL] [Abstract][Full Text] [Related]
9. Lifestyle and comorbid conditions as risk factors for community-acquired pneumonia in outpatient adults (NEUMO-ES-RISK project).
Rivero-Calle I; Cebey-López M; Pardo-Seco J; Yuste J; Redondo E; Vargas DA; Mascarós E; Díaz-Maroto JL; Linares-Rufo M; Jimeno I; Gil A; Molina J; Ocaña D; Martinón-Torres F
BMJ Open Respir Res; 2019; 6(1):e000359. PubMed ID: 31178994
[TBL] [Abstract][Full Text] [Related]
10. Current Status of Community-Acquired Pneumonia in Patients with Chronic Obstructive Pulmonary Disease.
Liu DS; Han XD; Liu XD
Chin Med J (Engl); 2018 May; 131(9):1086-1091. PubMed ID: 29692381
[TBL] [Abstract][Full Text] [Related]
11. Chronic obstructive pulmonary disease and risk of lung cancer: the importance of smoking and timing of diagnosis.
Powell HA; Iyen-Omofoman B; Baldwin DR; Hubbard RB; Tata LJ
J Thorac Oncol; 2013 Jan; 8(1):6-11. PubMed ID: 23196277
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology, severity, and treatment of chronic obstructive pulmonary disease in the United Kingdom by GOLD 2013.
Raluy-Callado M; Lambrelli D; MacLachlan S; Khalid JM
Int J Chron Obstruct Pulmon Dis; 2015; 10():925-37. PubMed ID: 25999708
[TBL] [Abstract][Full Text] [Related]
13. Systemic inflammatory pattern of patients with community-acquired pneumonia with and without COPD.
Crisafulli E; Menéndez R; Huerta A; Martinez R; Montull B; Clini E; Torres A
Chest; 2013 Apr; 143(4):1009-1017. PubMed ID: 23187314
[TBL] [Abstract][Full Text] [Related]
14. Clinical risk factors for admission with Pseudomonas and multidrug-resistant Pseudomonas community-acquired pneumonia.
Idigo AJ; Wells JM; Brown ML; Wiener HW; Griffin RL; Cutter G; Shrestha S; Lee RA
Antimicrob Resist Infect Control; 2022 Jul; 11(1):95. PubMed ID: 35836272
[TBL] [Abstract][Full Text] [Related]
15. Inhaled drugs as risk factors for community-acquired pneumonia.
Almirall J; Bolíbar I; Serra-Prat M; Palomera E; Roig J; Hospital I; Carandell E; Agustí M; Ayuso P; Estela A; Torres A;
Eur Respir J; 2010 Nov; 36(5):1080-7. PubMed ID: 20525710
[TBL] [Abstract][Full Text] [Related]
16. Chronic obstructive pulmonary disease in UK primary care: incidence and risk factors.
García Rodríguez LA; Wallander MA; Tolosa LB; Johansson S
COPD; 2009 Oct; 6(5):369-79. PubMed ID: 19863366
[TBL] [Abstract][Full Text] [Related]
17. DIAGNOSTIC AND TACTICAL IMPORTANCE OF STUDYING SHORT CHAIN FATTY ACIDS IN DIFFERENT BIOLOGICAL SUBSTRATES TOOK PLACE IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE, LUNG CANCER AND COMMUNITY-ACQUIRED PNEUMONIA DEVELOPED AFTER ANTICANCER THERAPY.
Ardatskaya MD; Ponomareva EV; Shevtsov VV; Evdokimova SA; Odintsov SV
Eksp Klin Gastroenterol; 2016; (11):17-25. PubMed ID: 29889440
[TBL] [Abstract][Full Text] [Related]
18. Clinical features, etiology and outcomes of community-acquired pneumonia in patients with chronic obstructive pulmonary disease.
Gómez-Junyent J; Garcia-Vidal C; Viasus D; Millat-Martínez P; Simonetti A; Santos MS; Ardanuy C; Dorca J; Carratalà J
PLoS One; 2014; 9(8):e105854. PubMed ID: 25166349
[TBL] [Abstract][Full Text] [Related]
19. Incidence and risk of chronic obstructive pulmonary disease in a Korean community-based cohort.
Leem AY; Park B; Kim YS; Jung JY; Won S
Int J Chron Obstruct Pulmon Dis; 2018; 13():509-517. PubMed ID: 29440888
[TBL] [Abstract][Full Text] [Related]
20. Decreased plasma phospholipid concentrations and increased acid sphingomyelinase activity are accurate biomarkers for community-acquired pneumonia.
Arshad H; Alfonso JCL; Franke R; Michaelis K; Araujo L; Habib A; Zboromyrska Y; Lücke E; Strungaru E; Akmatov MK; Hatzikirou H; Meyer-Hermann M; Petersmann A; Nauck M; Brönstrup M; Bilitewski U; Abel L; Sievers J; Vila J; Illig T; Schreiber J; Pessler F
J Transl Med; 2019 Nov; 17(1):365. PubMed ID: 31711507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
